With over 30 years of pharmaceutical and biologics experience, David has held progressively senior commercial roles in both private and public companies. He has successfully launched and commercialized a number of key biologics in the UK, United States, and other international markets, most recently, as VP Commercial Operations for Octapharma US. Prior to this, he was Global Vice President of Marketing Operations and Hemophilia for Baxter and also led their UK Bioscience business, following a 17-year career with Novartis. David holds a DMS from Kingston University in London.
.svg)
